{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:35:09Z","timestamp":1790411709433,"version":"4.1.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.ymgme.2007.10.007","type":"journal-article","created":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T08:25:38Z","timestamp":1196497538000},"page":"282-294","source":"Crossref","is-referenced-by-count":59,"title":["Monogenic pediatric dyslipidemias: Classification, genetics and clinical spectrum"],"prefix":"10.1016","volume":"93","author":[{"given":"Amit R.","family":"Rahalkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2007.10.007_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0022-3476(82)80579-9","article-title":"Familial hypercholesterolemia: Report of coronary death at age 3 in a homozygous child and prenatal diagnosis in a heterozygous sibling","volume":"100","author":"Rose","year":"1982","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2007.10.007_bib2","series-title":"Primary Hyperlipidemias","author":"Davignon","year":"2007"},{"key":"10.1016\/j.ymgme.2007.10.007_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.genom.5.061903.175930","article-title":"Genetics of atherosclerosis","volume":"5","author":"Lusis","year":"2004","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.ymgme.2007.10.007_bib4","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMe068026","article-title":"Protease variants, LDL, and coronary heart disease","volume":"354","author":"Tall","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2007.10.007_bib5","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1172\/JCI30163","article-title":"Molecular regulation of HDL metabolism and function: implications for novel therapies","volume":"116","author":"Rader","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2007.10.007_bib6","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMcp070061","article-title":"Clinical practice. Hypertriglyceridemia","volume":"357","author":"Brunzell","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2007.10.007_bib7","series-title":"The Metabolic & Molecular Bases of Inherited Disease","first-page":"2863","article-title":"Familial Hypercholesterolemia","author":"Goldstein","year":"2001"},{"key":"10.1016\/j.ymgme.2007.10.007_bib8","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/324647","article-title":"Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism","volume":"69","author":"Hegele","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2007.10.007_bib9","first-page":"108","article-title":"High blood cholesterol","volume":"6","year":"2003","journal-title":"Nutr. Clin. Care"},{"key":"10.1016\/j.ymgme.2007.10.007_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1079\/PNS19990022","article-title":"Lipoprotein atherogenicity: an overview of current mechanisms","volume":"58","author":"Griffin","year":"1999","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.ymgme.2007.10.007_bib11","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1172\/JCI107670","article-title":"Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood","volume":"53","author":"Kwiterovich","year":"1974","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2007.10.007_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ncpcardio0836","article-title":"Mechanisms of disease: genetic causes of familial hypercholesterolemia","volume":"4","author":"Soutar","year":"2007","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.ymgme.2007.10.007_bib13","series-title":"The Metabolic & Molecular Bases of Inherited Disease","first-page":"2717","article-title":"Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins","author":"Kane","year":"2001"},{"key":"10.1016\/j.ymgme.2007.10.007_bib14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1139\/g06-147","article-title":"Genetic susceptibility to heart disease in Canada: lessons from patients with familial hypercholesterolemia","volume":"49","author":"Hegele","year":"2006","journal-title":"Genome"},{"key":"10.1016\/j.ymgme.2007.10.007_bib15","author":"Tosi","year":"2006","journal-title":"Genetic defects causing familial hypercholesterolaemia: identification of deletions and duplications in the LDL-receptor gene and summary of all mutations found in patients attending the Hammersmith Hospital Lipid Clinic. Atherosclerosis"},{"key":"10.1016\/j.ymgme.2007.10.007_bib16","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1161\/01.ATV.18.10.1600","article-title":"Mutations in the low-density lipoprotein receptor gene in Chinese familial hypercholesterolemia patients","volume":"18","author":"Mak","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2007.10.007_bib17","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s100380200101","article-title":"Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred","volume":"47","author":"Takada","year":"2002","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2007.10.007_bib18","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/0140-6736(93)90815-X","article-title":"Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia","volume":"341","author":"Moorjani","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2007.10.007_bib19","first-page":"327","article-title":"Cellular pathology of homozygous familial hypercholesterolemia","volume":"97","author":"Buja","year":"1979","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2007.10.007_bib20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0002-8703(99)70485-0","article-title":"Characteristic cardiovascular manifestation in homozygous and heterozygous familial hypercholesterolemia","volume":"137","author":"Kawaguchi","year":"1999","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ymgme.2007.10.007_bib21","doi-asserted-by":"crossref","unstructured":"Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group, BMJ 303 (1991) 893\u2013896.","DOI":"10.1136\/bmj.303.6807.893"},{"key":"10.1016\/j.ymgme.2007.10.007_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00000441-198711000-00008","article-title":"The longest-lived patient with homozygous familial hypercholesterolemia secondary to a defect in internalization of the LDL receptor","volume":"294","author":"Komuro","year":"1987","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.ymgme.2007.10.007_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0140-6736(94)90968-7","article-title":"Homozygous familial hypercholesterolaemia","volume":"343","author":"Gagne","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2007.10.007_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.hlc.2006.10.019","article-title":"Guidelines for the diagnosis and management of familial hypercholesterolaemia","volume":"16","author":"Sullivan","year":"2007","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.ymgme.2007.10.007_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10545-007-0563-5","article-title":"Diagnosis of families with familial hypercholesterolaemia and\/or Apo B-100 defect by means of DNA analysis of LDL-receptor gene mutations","volume":"30","author":"Widhalm","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2007.10.007_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.ge.13.120179.001355","article-title":"The LDL receptor locus and the genetics of familial hypercholesterolemia","volume":"13","author":"Goldstein","year":"1979","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.ymgme.2007.10.007_bib27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2362.1995.tb01709.x","article-title":"Severe hypercholesterolaemia: unusual inheritance in an Italian pedigree","volume":"25","author":"Zuliani","year":"1995","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2007.10.007_bib28","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0022-2275(20)41638-4","article-title":"Nutritional regulation of cholesterol synthesis and apolipoprotein B kinetics: studies in patients with familial hypercholesterolemia and normal subjects treated with a high carbohydrate, low fat diet","volume":"32","author":"Stacpoole","year":"1991","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2007.10.007_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(02)00251-4","article-title":"LDL apheresis","volume":"167","author":"Thompson","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymgme.2007.10.007_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2006.02.030","article-title":"A systematic review of LDL apheresis in the treatment of cardiovascular disease","volume":"189","author":"Thompsen","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymgme.2007.10.007_bib31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0002-9343(90)90455-M","article-title":"Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia","volume":"88","author":"Berger","year":"1990","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ymgme.2007.10.007_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0167-5273(02)00420-5","article-title":"Familial hypercholesterolemia\u2014improving treatment and meeting guidelines","volume":"89","author":"Hopkins","year":"2003","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ymgme.2007.10.007_bib33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1517\/17425255.3.3.441","article-title":"Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials","volume":"3","author":"Sweeney","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ymgme.2007.10.007_bib34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.atherosclerosis.2005.06.039","article-title":"The effect of ezetimibe on serum lipids and lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis therapy","volume":"186","author":"Yamamoto","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymgme.2007.10.007_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF01233250","article-title":"Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemia","volume":"19","author":"Kozarsky","year":"1993","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.ymgme.2007.10.007_bib36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5551\/jat.14.94","article-title":"Long-term outcome after living donor liver transplantation for two cases of homozygous familial hypercholesterolemia from a heterozygous donor","volume":"14","author":"Kawagishi","year":"2007","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.ymgme.2007.10.007_bib37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa061189","article-title":"Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia","volume":"356","author":"Cuchel","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2007.10.007_bib38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(03)14234-1","article-title":"Dyslipidaemia","volume":"362","author":"Durrington","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2007.10.007_bib39","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1503\/cmaj.051313","article-title":"Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease","volume":"174","author":"Yuan","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.ymgme.2007.10.007_bib40","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/01.CIR.0000058166.99182.54","article-title":"Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children","volume":"107","author":"Wiegman","year":"2003","journal-title":"Circulation"},{"issue":"discussion 134","key":"10.1016\/j.ymgme.2007.10.007_bib41","first-page":"127","article-title":"Monogenic hypercholesterolaemias\u2014an evaluation of apolipoprotein B100 and LDL receptor gene polymorphisms","volume":"64","author":"Plewa","year":"2006","journal-title":"Kardiol. Pol."},{"key":"10.1016\/j.ymgme.2007.10.007_bib42","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0140-6736(69)90930-1","article-title":"Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states","volume":"2","author":"Slack","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2007.10.007_bib43","doi-asserted-by":"crossref","first-page":"1D","DOI":"10.1016\/0002-9149(93)90002-T","article-title":"Identification and management of heterozygous familial hypercholesterolemia: summary and recommendations from an NHLBI workshop","volume":"72","author":"Bild","year":"1993","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ymgme.2007.10.007_bib44","first-page":"525","article-title":"National cholesterol education program: report of the expert panel on blood cholesterol levels in children and adolescents","volume":"89","author":"Pediatrics","year":"1992","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2007.10.007_bib45","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1161\/ATVBAHA.107.145151","article-title":"A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia","volume":"27","author":"Avis","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2007.10.007_bib46","article-title":"Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis","author":"Arambepola","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymgme.2007.10.007_bib47","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCULATIONAHA.106.671016","article-title":"Statin treatment in children with familial hypercholesterolemia. The younger, the better","volume":"116","author":"Rodenburg","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ymgme.2007.10.007_bib48","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1161\/CIRCULATIONAHA.107.181946","article-title":"Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing","volume":"115","author":"McCrindle","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ymgme.2007.10.007_bib49","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1161\/01.ATV.0000094410.66558.9A","article-title":"Genetics, clinical phenotype, and molecular cell biology of autosomal recessive hypercholesterolemia","volume":"23","author":"Soutar","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2007.10.007_bib50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.atherosclerosis.2004.01.020","article-title":"Autosomal recessive hypercholesterolaemia: long-term follow up and response to treatment","volume":"174","author":"Naoumova","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymgme.2007.10.007_bib51","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.atherosclerosis.2005.11.016","article-title":"Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): a phenotypic comparison","volume":"188","author":"Pisciotta","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymgme.2007.10.007_bib52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2006.10.005","article-title":"Autosomal recessive hypercholesterolaemia: discrimination of ARH protein and LDLR function in the homozygous FH phenotype","volume":"378","author":"Abera","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2007.10.007_bib53","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0140-6736(02)07955-2","article-title":"Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis","volume":"359","author":"Arca","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2007.10.007_bib54","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1060458","article-title":"Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein","volume":"292","author":"Garcia","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2007.10.007_bib55","doi-asserted-by":"crossref","first-page":"40996","DOI":"10.1074\/jbc.M509394200","article-title":"The modular adaptor protein autosomal recessive hypercholesterolemia (ARH) promotes low density lipoprotein receptor clustering into clathrin-coated pits","volume":"280","author":"Garuti","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2007.10.007_bib56","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1242\/jcs.03217","article-title":"The adaptor protein Dab2 sorts LDL receptors into coated pits independently of AP-2 and ARH","volume":"119","author":"Maurer","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ymgme.2007.10.007_bib57","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.mol.0000137222.23784.2a","article-title":"Current management of severe homozygous hypercholesterolaemias","volume":"15","author":"Naoumova","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ymgme.2007.10.007_bib58","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1016\/S0021-9258(19)40786-2","article-title":"Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein. Observations in cultured fibroblasts from a patient with cholesteryl ester storage disease","volume":"250","author":"Goldstein","year":"1975","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2007.10.007_bib59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/geno.1996.0162","article-title":"Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity","volume":"33","author":"Aslanidis","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2007.10.007_bib60","series-title":"The Metabolic & Molecular Bases of Inherited Disease","first-page":"3551","article-title":"Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease","author":"Assmann","year":"2001"},{"key":"10.1016\/j.ymgme.2007.10.007_bib61","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1542\/peds.28.5.742","volume":"28","author":"Wolman","year":"1961","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2007.10.007_bib62","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1476-511X-4-26","article-title":"Treatment of dyslipidemia with lovastatin and ezetimibe in an adolescent with cholesterol ester storage disease","volume":"4","author":"Tadiboyina","year":"2005","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ymgme.2007.10.007_bib63","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bmt.1702557","article-title":"Wolman disease successfully treated by bone marrow transplantation","volume":"26","author":"Krivit","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2007.10.007_bib64","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/hmg\/10.16.1639","article-title":"Enzyme therapy for lysosomal acid lipase deficiency in the mouse","volume":"10","author":"Du","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2007.10.007_bib65","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1089\/104303402760128586","article-title":"Lysosomal acid lipase deficiency: correction of lipid storage by adenovirus-mediated gene transfer in mice","volume":"13","author":"Du","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2007.10.007_bib66","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00431-006-0298-6","article-title":"Successful treatment of Wolman disease by unrelated umbilical cord blood transplantation","volume":"166","author":"Stein","year":"2007","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2007.10.007_bib67","first-page":"180","article-title":"Prenatal diagnosis of heterozygosis in a pregnancy at risk for Wolman\u2019s disease at the 8th week of gestation","volume":"31","author":"Bona","year":"1989","journal-title":"Panminerva Med."},{"key":"10.1016\/j.ymgme.2007.10.007_bib68","series-title":"The Metabolic & Molecular Bases of Inherited Disease","first-page":"2961","article-title":"Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol","author":"Bj\u00f6rkhem","year":"2001"},{"key":"10.1016\/j.ymgme.2007.10.007_bib69","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0022-2275(20)34390-X","article-title":"Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis","volume":"26","author":"Salen","year":"1985","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2007.10.007_bib70","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1126\/science.290.5497.1771","article-title":"Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters","volume":"290","author":"Berge","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2007.10.007_bib71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/83799","article-title":"Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption","volume":"27","author":"Lee","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2007.10.007_bib72","doi-asserted-by":"crossref","first-page":"48275","DOI":"10.1074\/jbc.M310223200","article-title":"ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion","volume":"278","author":"Graf","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2007.10.007_bib73","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1194\/jlr.M300377-JLR200","article-title":"Selective sterol accumulation in ABCG5\/ABCG8-deficient mice","volume":"45","author":"Yu","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2007.10.007_bib74","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.0000116766.31036.03","article-title":"Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia","volume":"109","author":"Salen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ymgme.2007.10.007_bib75","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1194\/jlr.M400310-JLR200","article-title":"Phenotypic heterogeneity of sitosterolemia","volume":"45","author":"Wang","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2007.10.007_bib76","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1126\/science.1439810","article-title":"Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia","volume":"258","author":"Wetterau","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2007.10.007_bib77","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1194\/jlr.R200014-JLR200","article-title":"Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly","volume":"44","author":"Hussain","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2007.10.007_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2007.05.003","article-title":"Molecular diagnosis of hypobetalipoproteinemia: an ENID review","author":"Tarugi","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymgme.2007.10.007_bib79","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/10408360500295113","article-title":"Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism","volume":"42","author":"Hooper","year":"2005","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.ymgme.2007.10.007_bib80","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1161\/01.ATV.18.11.1745","article-title":"Frequency of ApoB and ApoE gene mutations as causes of hypobetalipoproteinemia in the framingham offspring population","volume":"18","author":"Welty","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2007.10.007_bib81","series-title":"Neuroacanthocytosis Syndromes","first-page":"21","article-title":"Acanthocytes and disorders of lipoprotein metabolism","author":"Al-Shali","year":"2004"},{"key":"10.1016\/j.ymgme.2007.10.007_bib82","first-page":"27228","volume":"270","author":"Wong","year":"1995","journal-title":"Identification of a mutation in the ileal sodium-dependent bile acid transporter gene that abolishes transport activity. J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2007.10.007_bib83","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1172\/JCI119355","article-title":"Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2)","volume":"99","author":"Oelkers","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2007.10.007_bib84","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0022-3476(79)80008-6","article-title":"Refractory infantile diarrhea due to primary bile acid malabsorption","volume":"94","author":"Heubi","year":"1979","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2007.10.007_bib85","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0016-5085(82)80009-7","article-title":"Primary bile acid malabsorption: defective in vitro ileal active bile acid transport","volume":"83","author":"Heubi","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymgme.2007.10.007_bib86","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00005176-200104000-00002","article-title":"Intestinal bile acid transport: biology, physiology, and pathophysiology","volume":"32","author":"Shneider","year":"2001","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymgme.2007.10.007_bib87","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.atherosclerosis.2003.08.019","article-title":"SC-435, an ileal apical sodium co-dependent bile acid transporter (ASBT) inhibitor lowers plasma cholesterol and reduces atherosclerosis in guinea pigs","volume":"171","author":"West","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymgme.2007.10.007_bib88","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1194\/jlr.M200469-JLR200","article-title":"Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE\u2212\/\u2212 mice by SC-435","volume":"44","author":"Bhat","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2007.10.007_bib89","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.bcp.2006.10.014","article-title":"Inhibition of the intestinal absorption of bile acids using cationic derivatives: mechanism and repercussions","volume":"73","author":"Vicens","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymgme.2007.10.007_bib90","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2007.10.007_bib91","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/hmg\/ddi128","article-title":"Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia","volume":"14","author":"Sun","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2007.10.007_bib92","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.0009-9163.2004.0238.x","article-title":"Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia","volume":"65","author":"Leren","year":"2004","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2007.10.007_bib93","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00439-003-1071-9","article-title":"A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree","volume":"114","author":"Timms","year":"2004","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2007.10.007_bib94","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/500615","article-title":"A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol","volume":"78","author":"Kotowski","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2007.10.007_bib95","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/humu.20316","volume":"27","author":"Yue","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2007.10.007_bib96","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2007.10.007_bib97","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.ATV.0000255311.26383.2f","article-title":"A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol","volume":"27","author":"Fasano","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2007.10.007_bib98","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1086\/507488","article-title":"Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote","volume":"79","author":"Zhao","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2007.10.007_bib99","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/MOL.0b013e3281338531","article-title":"Unravelling the functional significance of PCSK9","volume":"18","author":"Lambert","year":"2007","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ymgme.2007.10.007_bib100","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1194\/jlr.M400396-JLR200","article-title":"Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells","volume":"46","author":"Lalanne","year":"2005","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.ymgme.2007.10.007_bib101","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1073\/pnas.0402133101","article-title":"Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype","volume":"101","author":"Maxwell","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2007.10.007_bib102","first-page":"50630","volume":"279","author":"Park","year":"2004","journal-title":"Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin\/kexin type 9a in mouse liver. J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2007.10.007_bib103","series-title":"The Metabolic & Molecular Bases of Inherited Disease","first-page":"2937","article-title":"Familial analphalipoproteinemia: Tangier disease","author":"Assmann","year":"2001"},{"key":"10.1016\/j.ymgme.2007.10.007_bib104","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/11914","article-title":"The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease","volume":"22","author":"Bodzioch","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2007.10.007_bib105","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/11905","article-title":"Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency","volume":"22","author":"Brooks-Wilson","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2007.10.007_bib106","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/11921","article-title":"Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1","volume":"22","author":"Rust","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2007.10.007_bib107","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M704590200","article-title":"Mechanism of ATP-binding cassette transporter AI (ABCA1)-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles","author":"Vedhachalam","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2007.10.007_bib108","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1007\/s00018-005-5125-0","article-title":"Tangier disease: still more questions than answers","volume":"62","author":"Nofer","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymgme.2007.10.007_bib109","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1172\/JCI104907","article-title":"The inheritance of high density lipoprotein deficiency (Tangier disease)","volume":"43","author":"Fredrickson","year":"1964","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2007.10.007_bib110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0021-9150(94)90144-9","article-title":"Homozygous Tangier disease and cardiovascular disease","volume":"107","author":"Serfaty-Lacrosniere","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymgme.2007.10.007_bib111","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1191\/1358863x05vm593ra","article-title":"ABCA1 and atherosclerosis","volume":"10","author":"Soumian","year":"2005","journal-title":"Vasc. Med."},{"key":"10.1016\/j.ymgme.2007.10.007_bib112","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0009-9236(95)90213-9","article-title":"Microsomal enzyme inducers raise plasma high-density lipoprotein cholesterol levels in healthy control subjects but not in patients with primary hypoalphalipoproteinemia","volume":"57","author":"Franceschini","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ymgme.2007.10.007_bib113","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0828-282X(06)70310-5","article-title":"Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease","volume":"22","author":"McPherson","year":"2006","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ymgme.2007.10.007_bib114","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-2275(20)37433-2","article-title":"The molecular pathology of lecith cholesterol acyltransferase (LCAT) deficiency syndromes","volume":"38","author":"Kuivenhoven","year":"1997","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.ymgme.2007.10.007_bib115","first-page":"375","article-title":"LCAT deficiency: molecular and phenotypic characterization of an Italian family","volume":"19","author":"Gigante","year":"2006","journal-title":"J. Nephrol."},{"key":"10.1016\/j.ymgme.2007.10.007_bib116","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.atherosclerosis.2005.10.033","article-title":"Differential diagnosis of familial high density lipoprotein deficiency syndromes","volume":"186","author":"von Eckardstein","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymgme.2007.10.007_bib117","series-title":"The Metabolic & Molecular Bases of Inherited Disease","first-page":"2789","article-title":"Familial lipoprotein lipase deficiency Apo C-II deficiency and hepatic lipase deficiency","author":"Brunzell","year":"2001"},{"key":"10.1016\/j.ymgme.2007.10.007_bib118","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-291X(70)90468-7","article-title":"A specific apoprotein activator for lipoprotein lipase","volume":"41","author":"LaRosa","year":"1970","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2007.10.007_bib119","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1172\/JCI107171","article-title":"Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man","volume":"52","author":"Havel","year":"1973","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2007.10.007_bib120","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2796.1992.tb01256.x","article-title":"Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II","volume":"231","author":"Fojo","year":"1992","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ymgme.2007.10.007_bib121","first-page":"14","article-title":"Gene therapy for genetic lipoprotein lipase deficiency: from promise to practice","volume":"63","author":"Nierman","year":"2005","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.ymgme.2007.10.007_bib122","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0022-3476(98)70280-X","article-title":"Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study","volume":"133","author":"Feoli-Fonseca","year":"1998","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2007.10.007_bib123","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ana.10598","article-title":"Apolipoprotein C-II deficiency presenting as a lipid encephalopathy in infancy","volume":"53","author":"Wilson","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2007.10.007_bib124","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: its etiology, effects and treatment","volume":"176","author":"Yuan","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.ymgme.2007.10.007_bib125","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0025-7125(16)31430-4","article-title":"Chylomicronemia syndrome. Interaction of genetic and acquired hypertriglyceridemia","volume":"66","author":"Brunzell","year":"1982","journal-title":"Med. Clin. North. Am."},{"key":"10.1016\/j.ymgme.2007.10.007_bib126","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.mpa.0000202942.93578.dd","article-title":"Recurrent acute and chronic pancreatitis in two brothers with familial chylomicronemia syndrome","volume":"32","author":"Truninger","year":"2006","journal-title":"Pancreas"},{"key":"10.1016\/j.ymgme.2007.10.007_bib127","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1210\/jc.2005-1098","article-title":"Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis","volume":"90","author":"Kawashiri","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2007.10.007_bib128","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJM199609193351203","article-title":"Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene","volume":"335","author":"Benlian","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2007.10.007_bib129","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0021-9150(82)90116-2","article-title":"Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency","volume":"44","author":"Breckenridge","year":"1982","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymgme.2007.10.007_bib130","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1525-1470.2007.00415.x","article-title":"Familial chylomicronemia syndrome","volume":"24","author":"Sugandhan","year":"2007","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.ymgme.2007.10.007_bib131","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1089\/hum.2004.15.906","article-title":"Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation","volume":"15","author":"Ross","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2007.10.007_bib132","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/01.ATV.0000176971.27302.b0","article-title":"Complete rescue of lipoprotein lipase-deficient mice by somatic gene transfer of the naturally occurring LPLS447X beneficial mutation","volume":"25","author":"Ross","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2007.10.007_bib133","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1089\/hum.2005.16.1276","article-title":"Gene therapy for lipoprotein lipase deficiency: working toward clinical application","volume":"16","author":"Rip","year":"2005","journal-title":"Hum. Gene Ther."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719207004489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719207004489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T02:10:15Z","timestamp":1684116615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719207004489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":133,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1096719207004489"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2007.10.007","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}